Author Montserrat Carrasco-Triguero (Genentech, CA, USA) gives us an insight into her research career and her paper published in Bioanalysis: Immunogenicity of antibody–drug conjugates: observations across 8 molecules in 11 clinical trials, in this author’s perspective feature.
Browsing: Advanced therapies
In this interview, Kevork Kalaydjian (ZefSci; QC, Canada) explores the changing perspectives towards cannabis and how bioanalytical scientists can help improve the understanding of the scientific benefits and limitations of cannabis and its derivatives.
A study carried out by researchers based at the University of Cambridge (UK) and biotechnology company SomaLogic (CO, USA) has demonstrated that large-scale measurements of proteins in a single blood test could predict risk factors for a range of diseases.
Researchers from Dyno Therapeutics (MA, USA) and Harvard University (MA, USA) have reported a comprehensive machine-guided approach to produce improved adeno-associated virus capsids for gene therapy delivery.
Read the Bioanalysis Zone team’s top five take away messages from the 12th EBF Open Symposium, from automation to patient-centric sampling in this conference report.
Novel microfluidic impedance cytometry device: simultaneous measurement of single-cell lateral position and biophysical properties
A research team from Singapore University of Technology and Design (Singapore) has developed a microfluidic impedance flow cytometry device that could be capable of simultaneously measuring the lateral position and biophysical properties of single cells.
Researchers based at the University of Toronto (ON, CA) have developed a microfluidic device that could be used to separate malignant plasma cells from healthy red blood cells. The device could have the potential to detect and monitor blood cancer.
Aston University (Birmingham, UK) has announced the installation of the Waters (MA, USA) SELECT SERIES Cyclic™ ion mobility spectrometry mass spectrometer, the first commercial research installation of an instrument of its kind.
Novel artificial intelligence tool could revolutionize bioanalytical data review for precision drug development
Specialist in artificial intelligence-enabled solutions, Ariadne Software (PA, USA), announces the launch of Red Thread™, an innovative tool that could revolutionize bioanalytical data review for precision drug development.
In a pilot study, researchers from the School of Medicine at the University of Nottingham (UK), report the use of protein microarrays to rapidly screen blood samples for the presence of autoantibodies associated with breast cancer.